Biggest News Aggregation in the World
📰 Prediction System News

Page 2 - Prediction System News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Prediction System. Real-time updates on events, politics, business and more.

BBCNEWS BBC News June 4, 2024 16:19:00

Thank you so much for being here with us. your assessment of what the democrats are doing here? biden had to announce — democrats are doing here? biden had to announce up _ democrats are doing here? biden had to announce up around _ democrats are doing here? biden had to announce up around this _ democrats are doing here? biden had to announce up around this time. - to announce up around this time. this is around the same time barack 0bama announced his reelection. and ljy 0bama announced his ...
Joe Biden Barack 0bama Series Challenge Ljy 0bama Way To Go Republican Party

New Data Showing that Transgene and NEC's Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023

New Phase I data confirm promising immunogenicity and efficacy profile of TG4050, an individualized neoantigen cancer vaccine developed by Transgene in collaboration with NEC Corporation In the head
United States France General United Kingdom Institut Curie Alexandra Martinez Lucie Larguier

Petascale Supercomputer "PARAM Ganga" established at IIT Roorkee under National Supercomputing Mission – India Education | Latest Education News | Global Educational News

The National Supercomputing Mission (NSM) which is being steered jointly by Ministry of Electronics & Information Technology (MeiTY) and the Department of Science and Technology (DST) and implemented by Centre for Development of Advanced Computin
Madhya Pradesh Mohan Reddy Shri Sa Kumar Shri Sanjay Wandhekar Shri Naveen Kumar Manoranjan Parida

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

First Head & Neck Cancer Patient Treated in France in a Phase I Trial With TG4050 (myvac® Platform), Transgene's Innovative Individualized Immunotherapy

(Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that a first patient with head and neck cancer has been dosed with the Company’s innovative individualized immunotherapy, TG4050. This novel therapeutic vaccine is based on Transgene’s myvac® technology platform, which leverages cutting-edge Artificial Intelligence (AI) capabilities to customize the treatment for each patient. This innovative appr...
United States France General United Kingdom Alexandra Martinez Christian Ottensmeier Christophe Le Tourneau

First Head & Neck Cancer Patient Treated in France in a Phase I Trial With TG4050 (myvac Platform), Transgenes Innovative Individualized Immunotherapy

Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that a first patient with head and neck cancer has been dosed with the Company’s innovative individualized immunotherapy, TG4050. This novel therapeutic vaccine is based on Transgene’s myvac® technology platform, which leverages cutting-edge Artificial Intelligence (AI) capabilities to customize the treatment for each patient. This innova...
United States France General United Kingdom Lucie Larguier Jean Pierre Delord Sylvie Berrebi

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science